NIH awards $2.5 million for glioblastoma therapy research
1 report, 1 independent
Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The National Institutes of Health provided $2.5 million in Phase II funding to UP Oncolytics through a Small Business Innovation Research Fast-Track award. This funding is intended to advance an experimental Zika virus-based therapy for glioblastoma, an aggressive form of brain cancer. The research aims to move the therapy toward potential human clinical trials.
From prnewswire.com
Why it matters
The award supports the field of oncolytic virotherapy, which uses viruses to target and destroy cancer cells. This approach represents a new avenue of investigation for glioblastoma, a disease that has historically resisted treatment advances.
From prnewswire.com
Who's involved
- National Institutes of HealthProvided Phase II funding for the cancer therapy research
Keep exploring
The entities involved
-
National Institutes of Health
government organization in Shah Alam, Malaysia